Interest Paid, Excluding Capitalized Interest, Operating Activities of Aspira Women's Health Inc. from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary: Aspira Women's Health Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
Aspira Women's Health Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2025 was $9,000, a 50% increase year-over-year.
Aspira Women's Health Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $49,000, a 8.9% increase from 2023.
Aspira Women's Health Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $45,000, a 42% decline from 2022.
Aspira Women's Health Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $77,000, unchanged from 2021.
Source SEC data: View on sec.gov

Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)

Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)

Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)

Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

Aspira Women's Health Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$9,000	+$3,000	+50%	01 Jan 2025	31 Mar 2025	10-Q	19 May 2025	2025	Q1
Q1 2024	$6,000	-$12,000	-67%	01 Jan 2024	31 Mar 2024	10-Q	19 May 2025	2025	Q1
Q1 2023	$18,000	-$2,000	-10%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q1 2022	$20,000	-$9,000	-31%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q1 2021	$29,000	+$20,000	+222%	01 Jan 2021	31 Mar 2021	10-Q	11 May 2022	2022	Q1
Q1 2020	$9,000	-$2,000	-18%	01 Jan 2020	31 Mar 2020	10-Q	14 May 2021	2021	Q1
Q1 2019	$11,000	-$1,000	-8.3%	01 Jan 2019	31 Mar 2019	10-Q	14 May 2020	2020	Q1
Q1 2018	$12,000	$0	0%	01 Jan 2018	31 Mar 2018	10-Q	14 May 2019	2019	Q1
Q1 2017	$12,000	+$9,000	+300%	01 Jan 2017	31 Mar 2017	10-Q	14 May 2018	2018	Q1
Q1 2016	$3,000			01 Jan 2016	31 Mar 2016	10-Q	11 May 2017	2017	Q1
Q1 2012	$65,000	-$100,000	-61%	01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q1 2011	$165,000			01 Jan 2011	31 Mar 2011	10-Q	15 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$49,000	+$4,000	+8.9%	01 Jan 2024	31 Dec 2024	10-K	27 Mar 2025	2024	FY
2023	$45,000	-$32,000	-42%	01 Jan 2023	31 Dec 2023	10-K	27 Mar 2025	2024	FY
2022	$77,000	$0	0%	01 Jan 2022	31 Dec 2022	10-K	01 Apr 2024	2023	FY
2021	$77,000	+$40,000	+108%	01 Jan 2021	31 Dec 2021	10-K/A	26 Oct 2023	2022	FY
2020	$37,000	-$1,000	-2.6%	01 Jan 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY
2019	$38,000	-$6,000	-14%	01 Jan 2019	31 Dec 2019	10-K	31 Mar 2021	2020	FY
2018	$44,000	-$3,000	-6.4%	01 Jan 2018	31 Dec 2018	10-K	07 Apr 2020	2019	FY
2017	$47,000	+$9,000	+24%	01 Jan 2017	31 Dec 2017	10-K	28 Mar 2019	2018	FY
2016	$38,000	+$31,000	+443%	01 Jan 2016	31 Dec 2016	10-K	13 Mar 2018	2017	FY
2015	$7,000			01 Jan 2015	31 Dec 2015	10-K	31 Mar 2017	2016	FY
2012	$227,000	-$235,000	-51%	01 Jan 2012	31 Dec 2012	10-K	31 Mar 2014	2013	FY
2011	$462,000	-$945,000	-67%	01 Jan 2011	31 Dec 2011	10-K	01 Mar 2013	2012	FY
2010	$1,407,000			01 Jan 2010	31 Dec 2010	10-K	27 Mar 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.